The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results